Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000118032 | SCV000152353 | benign | not specified | 2013-08-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000118032 | SCV000171150 | benign | not specified | 2014-03-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000118032 | SCV000269708 | benign | not specified | 2015-01-13 | criteria provided, single submitter | clinical testing | p.Arg586Arg in exon 17 of POMT1: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 3.4% (291/8600) o f European American chromosomes by the NHLBI Exome Sequencing Project (http://ev s.gs.washington.edu/EVS/; dbSNP rs34954751). |
Prevention |
RCV000118032 | SCV000311739 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000528768 | SCV000649883 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2K; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1; Walker-Warburg congenital muscular dystrophy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000712815 | SCV000843349 | benign | not provided | 2017-08-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001166761 | SCV001329167 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2K | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Breakthrough Genomics, |
RCV000712815 | SCV005316725 | benign | not provided | criteria provided, single submitter | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000118032 | SCV001799166 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000118032 | SCV001922494 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000712815 | SCV001968723 | likely benign | not provided | no assertion criteria provided | clinical testing |